depression
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Sign the informed consent voluntarily; 2. Meet the western medicine diagnosis standard of depression; 3. It conforms to the diagnostic standard of depression in traditional Chinese medicine; 4. Hamilton Depression Scale 7 < HAMD-17 <= 24; 5. Aged 18-65 years old.
Exclusion criteria
Exclusion criteria: 1. Those diagnosed as other mental diseases, such as panic disorder, obsessive-compulsive disorder, schizophrenia, hypochondriasis, etc; 2. The patients who had used western medicine of anti anxiety, anti depression, anti psychosis and the same kind of traditional Chinese medicine in the first 4 weeks before entering the group; 3. Taking antidepressants or having antidepressant pharmacological effect without washout; 4. Pregnant or preparing pregnant or lactating women; 5. Hyperthyroidism, coronary heart disease, hypertension, irritable bowel syndrome and other endocrine, cardiovascular and digestive system diseases with depression; 6. Patients with organic mental disorders, psychoactive substances, non addictive substances and postpartum depression; 7. Patients who have a history of suicide or a tendency to commit suicide, with a suicide score >= 1 in HAMD-17; 8. Patients who participated in or are participating in other clinical trials within 1 month before enrollment; 9. Magnetic metal objects implanted near the head or in the brain, such as intracranial stent, cochlear implant, etc; 10. No monitoring or failure to complete the clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HAMD-17;SCL-90;PHQ-15; | — |
Secondary
| Measure | Time frame |
|---|---|
| PSQI;rMT; | — |
Countries
China